ACORN CAPITAL ADVISORS, LLC Long-Term Concentrated

Location: New York, NY

CIK: 0002054410 · Show all filings

Period: Q1 2026 (← Previous)

Filing Date: May 15, 2026

Total Value: $352M (100.0% shares, 0.0% debt)

Holdings (22)

New Positions (2)

JBIO JADE BIOSCEINCES INC 3.1%

Value $11.05M Shares 786,760 Est. Cost $14.79 Unrealized 0.0%

KPTI KARYOPHARM THERAPEUTICS INC 0.5%

Value $1.603M Shares 287,826 Est. Cost $7.62 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
JBIO	JADE BIOSCEINCES INC	786,760	$11.05M	3.1%	$14.79	0.0%	COM NEW	008064206
KPTI	KARYOPHARM THERAPEUTICS INC	287,826	$1.603M	0.5%	$7.62	0.0%	COMMON STOCK	48576U205

Increased Positions (4)

URGN UROGEN PHARMA LTD 8.6%

Value $30.09M (-11.3%) Shares 1,673,420 (+15.5%) Est. Cost $14.26 Unrealized +46.1%

LONA LEONABIO, INC. 1.9%

Value $6.523M (+71.7%) Shares 634,539 (+26.5%) Est. Cost $4.80 Unrealized +17.2%

CADL CANDEL THERAPEUTICS INC 4.9%

Value $17.21M (+18.0%) Shares 3,497,948 (+35.6%) Est. Cost $5.91 Unrealized -2.9%

BCAB BIOATLA INC 0.2%

Value $865K (-68.6%) Shares 5,406,345 (+11.8%) Est. Cost $1.34 Unrealized -79.7%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
URGN	UROGEN PHARMA LTD	1,673,420 (+15.5%)	$30.09M (-11.3%)	8.6%	$14.26	+46.1%	COM	M96088105
LONA	LEONABIO, INC.	634,539 (+26.5%)	$6.523M (+71.7%)	1.9%	$4.80	+17.2%	COMMON STOCK	04746L203
CADL	CANDEL THERAPEUTICS INC	3,497,948 (+35.6%)	$17.21M (+18.0%)	4.9%	$5.91	-2.9%	COM	137404109
BCAB	BIOATLA INC	5,406,345 (+11.8%)	$865K (-68.6%)	0.2%	$1.34	-79.7%	COM	09077B104

Exited Positions (1)

ACRV ACRIVON THERAPEUTICS INC 0.3%

Value $977K Shares 405,237 Est. Cost $7.27 Unrealized -74.6%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACRV	ACRIVON THERAPEUTICS INC	405,237	$977K	0.3%	$7.27	-74.6%	—	004890109

Decreased Positions (5)

HELP HELUS PHARMA INC. 2.1%

Value $7.393M (-42.6%) Shares 1,540,266 (-2.1%) Est. Cost $8.17 Unrealized -13.1%

CRDF CARDIF ONCOLOGY INC 0.8%

Value $2.855M (-48.2%) Shares 1,762,084 (-10.2%) Est. Cost $3.02 Unrealized -27.7%

JSPR JASPER THERAPEUTICS 0.4%

Value $1.242M (-62.0%) Shares 1,411,492 (-21.0%) Est. Cost $2.80 Unrealized -47.0%

QTTB Q32 BIO INC. 0.6%

Value $2.023M (+23.5%) Shares 315,052 (-36.1%) Est. Cost $31.58 Unrealized -87.5%

— X4 PHARMACEUTICALS INC 0.3%

Value $967K (-11.6%) Shares 234,039 (-14.4%) Est. Cost $1.91 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
HELP	HELUS PHARMA INC.	1,540,266 (-2.1%)	$7.393M (-42.6%)	2.1%	$8.17	-13.1%	COM STK	23256X407
CRDF	CARDIF ONCOLOGY INC	1,762,084 (-10.2%)	$2.855M (-48.2%)	0.8%	$3.02	-27.7%	COM	14147L108
JSPR	JASPER THERAPEUTICS	1,411,492 (-21.0%)	$1.242M (-62.0%)	0.4%	$2.80	-47.0%	COM	471871202
QTTB	Q32 BIO INC.	315,052 (-36.1%)	$2.023M (+23.5%)	0.6%	$31.58	-87.5%	COM	746964105
—	X4 PHARMACEUTICALS INC	234,039 (-14.4%)	$967K (-11.6%)	0.3%	$1.91	—	COM	98420X103

Unchanged Positions (11)

CGON CG ONCOLOGY INC 21.8%

Value $76.58M Shares 1,130,501 Est. Cost $34.21 Unrealized +53.2%

TERN TERNS PHARMACEUTICALS INC 26.2%

Value $92.06M Shares 1,746,264 Est. Cost $6.77 Unrealized +453.2%

VSTM VERASTEM INC 2.2%

Value $7.787M Shares 1,469,153 Est. Cost $6.27 Unrealized +3.2%

OKUR ONKURE THERAPEUTICS INC 3.3%

Value $11.76M Shares 2,839,674 Est. Cost $8.97 Unrealized -69.5%

BCAX BICARA THERAPEUTICS 3.6%

Value $12.8M Shares 643,382 Est. Cost $20.81 Unrealized -21.7%

PBYI PUMA BIOTECHNOLOGY INC 7.5%

Value $26.4M Shares 4,131,299 Est. Cost $2.92 Unrealized +126.9%

TRVI TREVI THERAPEUTICS INC 7.3%

Value $25.59M Shares 2,144,844 Est. Cost $3.31 Unrealized +230.9%

WHWK WHITEHAWK THERAPEUTICS INC 1.1%

Value $3.931M Shares 1,139,363 Est. Cost $2.27 Unrealized +24.5%

AURA AURA BIOSCIENCES INC 1.1%

Value $3.986M Shares 595,744 Est. Cost $7.57 Unrealized -28.1%

TARA PROTARA THERAPEUTICS INC 2.6%

Value $9.129M Shares 1,752,115 Est. Cost $3.29 Unrealized +87.9%

VYNE VYNE THERAPEUTICS INC 0.0%

Value $855 Shares 1,425 Est. Cost $2.55 Unrealized -77.6%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CGON	CG ONCOLOGY INC	1,130,501	$76.58M	21.8%	$34.21	+53.2%	COM	156944100
TERN	TERNS PHARMACEUTICALS INC	1,746,264	$92.06M	26.2%	$6.77	+453.2%	COM	880881107
VSTM	VERASTEM INC	1,469,153	$7.787M	2.2%	$6.27	+3.2%	COM	92337C203
OKUR	ONKURE THERAPEUTICS INC	2,839,674	$11.76M	3.3%	$8.97	-69.5%	CLASS A COM	68277Q105
BCAX	BICARA THERAPEUTICS	643,382	$12.8M	3.6%	$20.81	-21.7%	COM	055477103
PBYI	PUMA BIOTECHNOLOGY INC	4,131,299	$26.4M	7.5%	$2.92	+126.9%	COM	74587V107
TRVI	TREVI THERAPEUTICS INC	2,144,844	$25.59M	7.3%	$3.31	+230.9%	COM	89532M101
WHWK	WHITEHAWK THERAPEUTICS INC	1,139,363	$3.931M	1.1%	$2.27	+24.5%	COM	00032Q104
AURA	AURA BIOSCIENCES INC	595,744	$3.986M	1.1%	$7.57	-28.1%	COM	05153U107
TARA	PROTARA THERAPEUTICS INC	1,752,115	$9.129M	2.6%	$3.29	+87.9%	COM STK	74365U107
VYNE	VYNE THERAPEUTICS INC	1,425	$855	0.0%	$2.55	-77.6%	COM	92941V308